Publications While At Healthpartners
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: a multicentre, randomized controlled trial using continuous glucose monitoring
Diabetes, Obesity & Metabolism.
Map of science